ChinaBio Today -- According to a new report from Wicon International, the total amount of revenue generated by drug products in China during 2009 is expected to grow by 80 billion RMB ($12 billion) to reach 563 billion RMB ($82 billion), an increase of at least 16% over the year earlier. Experts think a variety of factors may move the final number much higher, closer to a 20-25% increase. The official PRC government statistics for the first five months of 2009 show total pharmaceutical sales reached 322 billion RMB ($47.4 billion) for the period, implying full-year 2009 would equal 773 billion RMB ($113.7 billion) if the industry keeps up its pace. More details...
